CADET

• Etoposide
• Thioguanine
• Daunorubicin Hydrochloride
• Cytarabine
• Carboplatin

Name

Etoposide

Alternate Names

Dom-Etoposide

Epipodophyllotoxin derivative

Epipodophyllotoxin ethylidene gluco-pyranoside

Eposine

Ethylidene-Lignan P

Etopophos

Podophyllotoxin derivative

Vepesid

VP 16-213

VP-16

VP-16213

Toposar

Abbreviations

EPEG

VP-16

VP-16-213

Category

Chemotherapy

Subcategory

Epipodophyllotoxin, topoisomerase II inhibitor

Plant alkaloid

NSC Number

141540

Primary Site

Gastric cancer

Hodgkins lymphoma

Lung cancer (NSCLC, SCLC)

Non-Hodgkin lymphoma

testicular cancer (Germ cell tumors)

Histology

None

Remarks

Plant alkaloid. FDA approved use on small-cell lung cancer, testicular cancer.

Coding

This drug should be coded

Name

Thioguanine

Alternate Names

6-Mercaptoguanine

6-Thioguanine

Lanvis

Tabloid

Tioguanin

WR-1141

Abbreviations

6-TG

TG

TT-6

TT-G

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

752

000752

Primary Site

None

Histology

None

Remarks

A purine analogue antineoplastic agent; antimetabolite. FDA approved use for acute non-lymphocytic leukemia.

Coding

This drug should be coded

Name

Daunorubicin Hydrochloride

Alternate Names

Acetyladriamycin

Cerubidine

Dauno-blastin

Daunomycin

Daunomycin-HCl

Daunorubicin

Daunorubicine

FI-6339

Leuk-aemomycin C

NDC-0082-4155

RP-13057

Rubidomycin

Rubidomycin HCl

Rubomycin C

Abbreviations

Daun

Dauno

DNM

DNR

DRB

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

082151

82151

Primary Site

Leukemia

Histology

None

Remarks

FDA approved use on ALL and ANLL; antitumor antibiotic

Coding

This drug should be coded

Name

Cytarabine

Alternate Names

AC-1075

Alexan

Ara-cytidine

Arabinocytidine

Arabinosylcytosine

Beta-Arabinosylcytosine

Cytarabin

Cytarabine

Cytarabinoside

Cytosar

Cytosar-U

Cytosine Arabinoside

Cytosine arabinoside hydrochloride

Spongocytidine HCL

Tarabine

Tarabine PFS

U-19920

U-19920A

WR-28453

Abbreviations

ara-C

CA

HDA

HDARA-C

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

063878

63878

Primary Site

ALL

AML

CML

head and neck

Hodgkin's disease

leukemia

Meningeal leukemia

NHL

Histology

None

Remarks

Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)

Coding

This drug should be coded

Name

Carboplatin

Alternate Names

JM 8

JM-8

JM8

Paraplatin

Abbreviations

CBDCA

Category

Chemotherapy

Subcategory

Alkylating agent

Platinum analog

NSC Number

241240

Primary Site

All cancers

Histology

None

Remarks

A platinum-salt alkylating agent.

Coding

This drug should be coded